We are the authority in real-world evidence, discovering data, developing insights, and delivering optimal solutions to realize maximum value.


STATinMED is the authority in real-world evidence, providing premier services that lead to better, faster decisions, customized solutions, and successful partnerships.

Learn More


Our consultative, strategic approach saves time while maintaining integrity based on extensive experience with in-house and commercially-available data to meet your needs.

Learn More


Whether it’s an abstract, poster, manuscript or presentation, key value messages are communicated. We are proud of over 900 peer-reviewed publications in dozens of therapeutic areas!

Learn More

The amazing research collaboration between STATinMED and our team has already led to a comprehensive body of evidence to inform confident decision-making for many patients.

Joint Partnership Alliance Real-World Evidence Executive

Thanks to the entire STATinMED team for all of your hard work and support with many projects – especially for the countless hours, expertise and thoroughness on recent projects. It has been a pleasure to work with you and the team.

Market Access Executive global biopharmaceutical company

The abstract has been accepted as a podium presentation at ISPOR! Many thanks to the team for all the hard work over the last several months!

HEOR Executive global biopharmaceutical company

Let’s give kudos to ourselves for everything we have accomplished together. Please share with STATinMED colleagues involved in the study–let them know our deep appreciation for all of them.

Real-World Evidence Executive Joint Partnership Alliance

On behalf of our study team, I would like to thank you all for your tremendous help on the study. Acceptance by Stroke is a watershed moment for the Real-World Data program.

Real-World Evidence Executive, Joint Partnership Alliance two global biopharmaceutical companies


Read more about our perspective on various topics.

FAQs: Real-World Questions, Answered.

    Want to learn more about STATinMED and the power of RWD Insights? Here we share some common questions, with answers about our data source and approach. Is your data source HIPAA-compliant? Yes, our data source is de-identified, tokenized, and...

Read More

2022 Spring Newsletter

Open the door to RWE. Read our latest newsletter for highlights from the Spring conference season.

Read More

Targeted Epidemiology in RWE: Purpose and Patients with Rare Disease

Study Purpose and Population Epidemiology of rare diseases is important for clinicians to consider, as prevalence and incidence inform the healthcare community about likelihood of disease within an at-risk population. Studies in epidemiology also help to...

Read More

Schedule Your Consultation Today